(Q43715235)

26 November 2017

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate (English)

1 reference

26 November 2017

1 reference

6

Razelle Kurzrock

1 reference

26 November 2017

4

Donald A Barkauskas

1 reference

26 November 2017

Shumei Kato

1

1 reference

26 November 2017

Aaron Goodman

series ordinal

2

1 reference

26 November 2017

Vighnesh Walavalkar

series ordinal

3

1 reference

26 November 2017

Andrew Sharabi

series ordinal

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

28 March 2017

1 reference

26 November 2017

Clinical Cancer Research

1 reference

26 November 2017

23

1 reference

26 November 2017

15

1 reference

26 November 2017

4242-4250

1 reference

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

26 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Clinical Overview of MDM2/X-Targeted Therapies

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Pseudoprogression and Immune-Related Response in Solid Tumors

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Nivolumab in previously untreated melanoma without BRAF mutation

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

The regulation of MDM2 oncogene and its impact on human cancers

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

MDM2, MDMX and p53 in oncogenesis and cancer therapy

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

IFN regulatory factor 8 regulates MDM2 in germinal center B cells

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

JAK-STAT signaling: from interferons to cytokines

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647162

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

27 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28351930

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-16-3133

1 reference

26 November 2017

0 references

1 reference